NRGSX
Price
$61.95
Change
-$0.68 (-1.09%)
Updated
Nov 13 closing price
Net Assets
8.43B
WRGCX
Price
$21.14
Change
-$0.76 (-3.47%)
Updated
Nov 13 closing price
Net Assets
1.07B
Interact to see
Advertisement

NRGSX vs WRGCX

Header iconNRGSX vs WRGCX Comparison
Open Charts NRGSX vs WRGCXBanner chart's image
Neuberger Berman Genesis R6
Price$61.95
Change-$0.68 (-1.09%)
VolumeN/A
Net Assets8.43B
Macquarie Small Cap Growth C
Price$21.14
Change-$0.76 (-3.47%)
VolumeN/A
Net Assets1.07B
NRGSX vs WRGCX Comparison Chart in %
View a ticker or compare two or three
VS
NRGSX vs. WRGCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRGSX is a Hold and WRGCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.43B vs. WRGCX (1.07B). NRGSX pays higher dividends than WRGCX: NRGSX (0.07) vs WRGCX (0.00). NRGSX was incepted earlier than WRGCX: NRGSX (13 years) vs WRGCX (33 years). WRGCX (2.04) is less costly to investors than NRGSX (0.74). WRGCX is a more actively managed with annual turnover of: 76.00 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than WRGCX: NRGSX (0) vs WRGCX (1000). WRGCX annual gain was more profitable for investors over the last year : -2.93 vs. NRGSX (-13.93). NRGSX return over 5 years is better than : -6.57 vs. WRGCX (-51.80).
NRGSXWRGCXNRGSX / WRGCX
Total Expense Ratio0.741.8839%
Annual Report Gross Expense Ratio0.742.0436%
Fund Existence13 years33 years-
Gain YTD-4.16213.354-31%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.43B1.07B785%
Annual Yield % from dividends0.070.00-
Returns for 1 year-13.93-2.93476%
Returns for 3 years-1.730.97-179%
Returns for 5 years-6.57-51.8013%
Returns for 10 years10.77-51.96-21%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKTI74.612.77
+3.86%
BK Technologies Corp
BSX104.131.63
+1.59%
Boston Scientific Corp
OBDC12.100.03
+0.25%
Blue Owl Capital Corp
LIVE11.75-0.30
-2.49%
Live Ventures
NVCR11.36-0.50
-4.22%
NovoCure Limited